Research Doctors are Looking for Individuals with Memory Loss

Great Lakes Clinical Trials is now seeking participants for a research study of older adults, ages 60-85, who are starting to experience memory loss, more than would be expected of normal aging.  If you or a loved one are having memory problems that are affecting daily routines, and others are starting to notice those memory problems as well, then this program may be a good option.

The main purpose of this screening program is to identify individuals who are experiencing mild memory loss and also have changes in their brain that could be a sign of having a greater risk for developing Alzheimer's disease in the future.

This research program involves two clinic visits.

  1. At the first visit we will review your medical history, conduct basic memory assessments and perform a ECG.
     
  2. If you qualify based on the results of your first visit, you will be asked to complete your second visit, which involves a brain scan (called a PET scan) performed at Northwest Community Hospital.  

For your participation, you will receive compensation of $75 for each visit you complete.

Based on the results for these screening tests, the research staff will let you know if you qualify to participate in the second part of the program, which is an 18-month research study of an investigational medication to evaluate the possible slowing of memory loss compared to placebo.  This is called the Periscope Study.  

All study-related medical care, tests and medications are provided at no cost and insurance or Medicare is not required.  In addition, you may receive compensation for your participation.

Interested?  Call 847-310-7480 to set up your appointment or visit our website at www.greatlakesclinicaltrials.com.

Great Lakes Clinical Trials featured in Alzheimer's Prevention Video

Great Lakes Clinical Trials is proud to have provided support, staffing and facility to the production of this important Alzheimer's prevention video. 

The filming took place at our clinic over the course of three days and most of the staff and patients seen in the video are from the Great Lakes Clinical Trials family. 

"Videos like this clearly explain the importance of participation in Alzheimer's Disease Prevention research studies," commented Steve satek, President of Great Lakes Clinical Trials.  "Our team is committed to making a difference and doing everything in our power to find a cure or prevention for Alzheimer's disease."

For more information on participating on any of our research program, please contact our Patient Care Representatives at (773) 275-3500 or click here for more information.

Diabetes? Cholesterol? Fatty Liver?

Concerned about Metabolic Health? 

Great Lakes Clinical Trials is now offering Free Lab Tests for diabetes, cholesterol and/or liver function.

shutterstock_215495941.jpg

Step 1:  Eligibility

  • 18 to 70 years of age
  • Slightly to moderately overweight

Step 2: Free Clinic Assessment

  • Fingerstick test for diabetes and cholesterol
  • Blood draw for liver enzymes
  • Blood pressure check

Step 3: Participate

Results of these tests may help determine if you qualify for any of our research studies.  You are under no obligation to join a study.


To learn more or to schedule your free lab tests, call our center directly at (773) 275-3500

Depression Research Study

Still having symptoms of depression even with your current antidepressant?  Help us research an investigational medication for major depressive disorder (MDD)

shutterstock_526299895.jpg

About The Study

The study will assess the safety and effectiveness of an investigational medication for MDD. This study will include about 280 people with MDD.  Patients will take the study medication in addition to continuing their usual antidepressant medication during the study.  The study will last for about 12 weeks (approximately 4 months).

Step 1: Eligibility

You may be able to take part in this study if you: 

  • are 18-64 years of age 
  • have been diagnosed with MDD
  • have taken your antidepressants that did not work well for you
  • currently still feel depressed  

Step 2: Free Clinic Assessment

Our professional staff will provide a free assessment of your condition to determine if a study is right for you.

 Step 3: Participate

If you’re eligible and choose to participate, you’ll be joining the fight to develop new treatments for depression.

If you are interested in joining this trial, please call our center directly at (773) 275-3500 to speak with one of our staff today or visit www.greatlakesclinicaltrials.com/depression

Diabetic Nerve Pain Study

Qualified volunteers may receive no-cost study drug with reimbursement for time & travel.

Aptinyx DPN (Social Media).jpg

If you have Type 2 Diabetes and are experiencing nerve pain in your feet and/or legs, you may be able to participate in a clinical trial.

An investigational drug is being studied for patients who have diabetic nerve pain (also called painful diabetic peripheral neuropathy or pain associated with diabetic peripheral neuropathy). The purpose of this study is to evaluate if the investigational drug works and determine its safety.

You may be able to participate if you:

  • Have pain associated with diabetic peripheral neuropathy in your feet and/or legs
  • Are 18-70 years of age
  • Have type 2 diabetes

The study team will also review other criteria with you to determine your full eligibility.

You will receive all study-related care and study-related drug at no cost.

This trial will involve 5 visits to our clinic over 6 to 9 weeks consisting of these steps:

  • Screening Period (1 clinic visit):  1 to 4 weeks
  • Maintenance Period (3 clinic visits):  4 weeks during which you will need to swallow 2 capsules once daily
  • Follow-up Period (1 clinic visit):  1 week after the last dose for assessment of side effects and lab tests.

If you are interested in joining this trial, please call our center directly at (773) 275-3500 to speak with one of our staff today or visit www.greatlakesclinicaltrials.com

What is Psoriatic Arthritis?

Some people might hear “psoriasis” and think of the skin disease that causes itchy, scaly rashes and crumbling nails. It's true, psoriasis is an autoimmune disease that primarily affects the skin. But about 30 percent of people with psoriasis also develop a form of inflammatory arthritis called psoriatic arthritis (PsA). Like psoriasis, PsA is an autoimmune disease, meaning it occurs when the body’s immune system mistakenly attacks healthy tissue, in this case the joints and skin. The faulty immune response causes inflammation that triggers joint pain, stiffness and swelling. The inflammation can affect the entire body and may lead to permanent joint and tissue damage if it is not treated early and aggressively.

Most people with psoriatic arthritis have skin symptoms before joint symptoms. However, sometimes the joint pain and stiffness strikes first. In some cases, people get psoriatic arthritis without any skin changes.

The disease may lay dormant in the body until triggered by some outside influence, such as a common throat infection. Another theory suggesting that bacteria on the skin triggers the immune response that leads to joint inflammation has yet to be proven.

shutterstock_266750687.jpg

Types of Psoriatic Arthritis

There are five types of psoriatic arthritis:

  • Symmetric psoriatic arthritis. This makes up about 50 percent of psoriatic arthritis cases. Symmetric means it affects joints on both sides of the body at the same time. This type of arthritis is similar to rheumatoid arthritis.
  • Asymmetric psoriatic arthritis: Often mild, this type of PsA appears in 35 percent of people with the condition. It’s called asymmetric because it doesn’t appear in the same joints on both sides of the body.
  • Distal psoriatic arthritis: This type causes inflammation and stiffness near the ends of the fingers and toes, along with changes in toenails and fingernails such as pitting, white spots and lifting from the nail bed.
  • Spondylitis: Pain and stiffness in the spine and neck are hallmarks of this form of PsA.
  • Arthritis mutilans: Although considered the most severe form of PsA, arthritis mutilans affects only 5 percent of people who have the condition. It causes deformities in the small joints at the ends of the fingers and toes, and can destroy them almost completely.

Who’s Affected?

According to the Annals of Rheumatic Disease, between 6 and 42 percent of people who have psoriasis will develop psoriatic arthritis. The disease usually appears between the ages of 30 and 55 in people who have psoriasis, but it can be diagnosed during childhood. Unlike many autoimmune diseases, men and women are equally at risk for developing this condition.

Article from www.arthritis.org

Almond Research Study for Patients with Pre-Diabetes

 Great Lakes Clinical Trials is looking for male and female volunteers for a research study involving the daily consumption almonds.

What is the objective of the study? 
The purpose of this study is to assess the Effects of Replacing Refined Carbohydrates with Almonds on Insulin Sensitivity in Men and Women

What is my time commitment to the study?
You will be asked to visit our clinic on 7 occasions over approximately 4 months. The study visits will last between 30 and 180 minutes.

 Is there a study stipend?
There is no cost for participation in this study. All study foods, tests and procedures are free of charge and we do not bill insurance. For your participation, you will receive up to $490.

You may be able to participate if you are:

  1. between 18-69 years old
  2. currently diagnosed as having pre-diabetes (slightly elevated HbA1c or glucose)
  3. willing to consume almonds
  4. willing to avoid other nuts and nut butters during the study

Note that other entry criteria will apply and can be discussed with our study staff. Lab values, blood pressure and weight measurements will be verified at your first clinic visit.

If you are interested in joining this trial, please call our center directly at (773) 275-3500 to speak with one of our staff today or visit www.greatlakesclinicaltrials.com/almond

Before the memories are lost: Participate in Alzheimer’s research

Could you be the solution to ending Alzheimer’s disease? Thousands of seniors from across Chicagoland have already joined the fight by participating in clinical trials. Much progress has been made, but tens of thousands more participants are needed to win the battle.

Clinical trials are well-planned research studies that assess interventions such as new medications, exercise or changes in diet. Trials are the primary way that researchers find out if a new medication is safe and effective in people. All prescription medications must be studied in clinical trials before they become available to the general public.

According to the Alzheimer’s Association, there are more than 100 Alzheimer’s disease and related memory studies recruiting participants at over 500 research clinics in the United States.

One such research clinic is Great Lakes Clinical Trials, located in Arlington Heights on the campus of the Lutheran Home. A primary focus of Great Lakes Clinical Trials has been to find prevention for Alzheimer’s disease.

Great_Lakes_Preview-8.jpg

Steve Satek, president of Great Lakes Clinical Trials, explains why he opened a clinic at the Lutheran Home.

“Many people think clinical trials are only conducted at major hospitals and medical centers. In reality, across the country the majority of clinical trials are conducted at private physicians’ offices. We opened our clinic at the Lutheran Home to provide convenient access to research in the Northwest suburbs of Chicago. I grew up in this community and I know firsthand that the local residents can get behind an important cause.”

Participation in a memory loss prevention trial is a big decision. Older adults who join prevention studies are generally healthy and are not experiencing significant memory loss beyond normal aging. “This presents a challenge, as these healthy individuals don’t necessarily want to go to a doctor unless they are sick,” added Satek. “They typically don’t want to take a medication unless they really need it. Joining a clinical trial is not always at the top of a todo list.”

Many seniors opt to participate in research studies as part of their legacy. They are doing it for their children and grandchildren, with the thought that if this generation doesn’t find a way to prevent Alzheimer’s, then the responsibility will be a passed to the next generation. These participants understand that the only way for to find a cure is for today’s seniors to get involved.Nowis the time.

As a testament to its commitment to the cause, this past year Great Lakes Clinical Trials had the honor of joining an international network of research clinics called the Global Alzheimer’s Platform. This network includes top-performing, respected academic and private commercial institutions that share the goal of streamlining clinical research and drug development for Alzheimer’s disease. These clinics are committed to sharing information and fostering a collaborative environment across the network.

Participation in research at Great Lakes Clinical Trials is always free. Insurance is not required and appointments can generally be made within a week or two. Patients remain under the care or their regular doctor and Great Lakes’ board-certified physicians provide supplemental care. Great Lakes may even be able to provide free transportation for clinic visits.

Do something unforgettable today. Take part in research to help preventAlzheimer’s disease. To learn how to participate, call Great Lakes Clinical Trials at (773) 275-3500 or visit www.greatlakesclinicaltrials.com.

Daily Herald Article
Healthy You Section, Page 2
FRIDAY, JANUARY 26, 2018

Great Lakes Clinical Trials Contributes to Successful Migraine Research Program

Great Lakes Clinical Trial staff, under the direction of Medical Director, Jeffrey Ross, MD, are pleased to share the results of Alder Biopharmaceuticals' migraine research program which were released earlier today.  A press release has been issued entitled,

Alder Announces Eptinezumab Significantly Reduces Migraine Risk Meets Primary and All Key Secondary Endpoints in Pivotal PROMISE 2 Phase 3 Trial for Chronic Migraine Prevention

The highlights of the press release include:

 Jeffrey Ross, MD Medical Director

Jeffrey Ross, MD
Medical Director

  • Highly statistically significant results with rapid prevention beginning Day One
  • 50%, 75%, 100% responder rates by month one sustained for three months
  • 15% of patients had no migraines for a full three months

To view a full copy of the press release click HERE.

"Our clinic is an independent and unbiased research facility for the testing of investigational medicals for a variety of diseases, including migraines.  Our primary service is for our medical staff to work closely with our patients and determine if a new medication works or not, and assess its safety." commented Steve Satek, Great Lakes Clinical Trials President.  "When we hear positive results from research programs which we conducted on such as this Alder Biopharmaceuticals migraine program, it reaffirms our company's mission to advance the science of medicine and  improve the quality of life and health of patients around the world.

All services at Great Lakes Clinical Trials are provided at no cost and are conducted by board-certified physicians.  No insurance required.  For a full listing of studies currently being conducted at Great Lakes Clinical Trials, visit our Studies page by clicking here.